NCT03639610 2023-03-10
BRIDGE
Oncopeptides AB
Phase 2 Terminated
Clinical Trials
4 trialsNCT01575925 2022-11-04
POM Renal
Celgene
Phase 1 Completed
NCT02045017 2021-08-27
Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency
Celgene
Phase 2 Completed
NCT01337752 2020-12-17
Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency
Novartis
Phase 2 Completed